anti-CD19 allo-CAR-T cells
Anti-CD19 allo-CAR-T
Phase 1 mab active
Quick answer
anti-CD19 allo-CAR-T cells for Relapsed Adult ALL is a Phase 1 program (mab) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- Relapsed Adult ALL
- Phase
- Phase 1
- Modality
- mab
- Status
- active